Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rose J Miller

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Stem Cells (Dayton, Ohio)|March 23, 2011
Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiformeKate W R Broadley, Martin K Hunn, Kathryn J Farrand, et al.
Nature Communications|December 31, 2024
The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidaseRose J Miller, Ian A Durie, Aaron D Gingerich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2012
Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for gliomaMartin K Hunn, Kathryn J Farrand, Kate W R Broadley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2024
Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 PromiscuityAlexandra A Abu-Shmais, Rose J Miller, Alexis K Janke, et al.
Journal of Virology|November 5, 2025
N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineagesCaroline K Page, M H M Mubassir, Pradeep Chopra, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Stem Cells (Dayton, Ohio)|March 23, 2011
Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiformeKate W R Broadley, Martin K Hunn, Kathryn J Farrand, et al.
Nature Communications|December 31, 2024
The structural basis of protective and nonprotective human monoclonal antibodies targeting the parainfluenza virus type 3 hemagglutinin-neuraminidaseRose J Miller, Ian A Durie, Aaron D Gingerich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2012
Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for gliomaMartin K Hunn, Kathryn J Farrand, Kate W R Broadley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 2024
Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 PromiscuityAlexandra A Abu-Shmais, Rose J Miller, Alexis K Janke, et al.
Journal of Virology|November 5, 2025
N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineagesCaroline K Page, M H M Mubassir, Pradeep Chopra, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magady Khalil, et al.
Cell Reports. Medicine|January 17, 2026
A potently neutralizing and protective human antibody targeting antigenic site V on RSV and hMPV fusion glycoproteinAlexandra A Abu-Shmais, Luqiang Guo, Ahmed Magdy Khalil, et al.
Pageof 2